Mechanism of Growth Inhibition of Prostate Cancer Xenografts by Valproic Acid
Valproic Acid (VPA), a histone deacetylase inhibitor, has been demonstrated to cause a marked decrease in proliferation of prostate cancer (PCa) cells in vitro and a significant reduction in tumor volume in vivo. The goal of this study is to better understand the VPA-induced growth inhibition in viv...
Main Authors: | Abhinav Sidana, Muwen Wang, Shabana Shabbeer, Wasim H. Chowdhury, George Netto, Shawn E. Lupold, Michael Carducci, Ronald Rodriguez |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2012-01-01
|
Series: | Journal of Biomedicine and Biotechnology |
Online Access: | http://dx.doi.org/10.1155/2012/180363 |
Similar Items
-
Does Valproic Acid Induce Neuroendocrine Differentiation in Prostate Cancer?
by: Abhinav Sidana, et al.
Published: (2011-01-01) -
Inhibition of leukemic cells by valproic acid, an HDAC inhibitor, in xenograft tumors
by: Zhang Z, et al.
Published: (2013-06-01) -
Testosterone inhibits the growth of prostate cancer xenografts in nude mice
by: Weitao Song, et al.
Published: (2017-09-01) -
A real time Metridia luciferase based non-invasive reporter assay of mammalian cell viability and cytotoxicity via the β-actin promoter and enhancer.
by: Shawn E Lupold, et al.
Published: (2012-01-01) -
Inhibition of Stromal PlGF Suppresses the Growth of Prostate Cancer Xenografts
by: Dietmar Abraham, et al.
Published: (2013-09-01)